PersonALL
The project was co-financed/financed by the National Centre for Research and Development under the 3rd competition of the strategic research and development program “Prevention and Treatment of Civilization Diseases” – STRATEGMED.
Title: “Personalization of Acute Lymphoblastic Leukemia Treatment in Children in Poland.”
PROJECT OBJECTIVE:
The PersonALL project focuses on research into the molecular identification of acute lymphoblastic leukemia (ALL), the most common malignant tumor in children, with the aim of personalizing treatment. Planned state-of-the-art molecular studies aim to identify new prognostic factors. Research will also be conducted on new biomarkers in ALL, utilizing genomics, proteomics, and transcriptomics. Another objective of the project is to collect biological material for mass analyses (including cell banking and nucleic acid storage).
EXPECTED OUTCOMES:
The overall outcome of the PersonALL project will be the development of innovative diagnostics for ALL in children, enabling more targeted therapy and potentially leading to improved treatment outcomes.
PROJECT VALUE: PLN 13,738,483
including funding of PLN 13,506,515.
The consortium includes:
- Medical University of Silesia in Katowice – Lead Partner
- Sieć Badawcza Łukasiewicz – Instytut Technik Innowacyjnych EMAG
- Medical University of Lodz
- Institute of Human Genetics, Polish Academy of Sciences
- Nicolaus Copernicus University in Toruń
- Ludwik Rydygier Collegium Medicum in Bydgoszcz
- Medical University of Lublin
- Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu
- Karol Marcinkowski Medical University in Poznań
- Medical University of Warsaw
- Medical University of Gdańsk
- Pomeranian Medical University in Szczecin
- Medical University of Bialystok
- Netology sp. z o.o.
